T. Rowe Price Associates’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.2M Buy
294,994
+4,925
+2% +$469K ﹤0.01% 905
2025
Q4
$23.5M Sell
290,069
-238,310
-45% -$20.5M ﹤0.01% 1025
2025
Q3
$46.2M Buy
528,379
+240,652
+84% +$21.5M ﹤0.01% 827
2025
Q2
$23.9M Buy
287,727
+1,992
+0.7% +$166K ﹤0.01% 921
2025
Q1
$24M Buy
285,735
+956
+0.3% +$88.9K ﹤0.01% 910
2024
Q4
$26.2M Buy
284,779
+1,680
+0.6% +$162K ﹤0.01% 925
2024
Q3
$26.3M Buy
283,099
+3,817
+1% +$331K ﹤0.01% 936
2024
Q2
$23M Buy
279,282
+273,639
+4,849% +$20.1M ﹤0.01% 924
2024
Q1
$375K Buy
5,643
+695
+14% +$42.9K ﹤0.01% 2328
2023
Q4
$281K Buy
4,948
+517
+12% +$27.1K ﹤0.01% 2405
2023
Q3
$242K Buy
4,431
+469
+12% +$27.8K ﹤0.01% 2429
2023
Q2
$267K Buy
+3,962
New +$242K ﹤0.01% 2417
2021
Q4
Sell
-10,014
Closed -$532K 3019
2021
Q3
$532K Buy
10,014
+54
+0.5% +$3.04K ﹤0.01% 2359
2021
Q2
$608K Sell
9,960
-2,740
-22% -$146K ﹤0.01% 2297
2021
Q1
$620K Sell
12,700
-18
-0.1% -$844 ﹤0.01% 2265
2020
Q4
$515K Sell
12,718
-99
-0.8% -$3.54K ﹤0.01% 2225
2020
Q3
$417K Hold
12,817
﹤0.01% 2165
2020
Q2
$338K Sell
12,817
-3,148
-20% -$82.3K ﹤0.01% 2209
2020
Q1
$398K Buy
15,965
+228
+1% +$7.04K ﹤0.01% 2085
2019
Q4
$566K Buy
15,737
+657
+4% +$22.7K ﹤0.01% 2112
2019
Q3
$515K Buy
15,080
+117
+0.8% +$3.74K ﹤0.01% 2085
2019
Q2
$419K Hold
14,963
﹤0.01% 2179
2019
Q1
$464K Buy
14,963
+2,950
+25% +$78.7K ﹤0.01% 2142
2018
Q4
$284K Sell
12,013
-3,671
-23% -$100K ﹤0.01% 2307
2018
Q3
$608K Buy
15,684
+96
+0.6% +$3.46K ﹤0.01% 2076
2018
Q2
$522K Buy
15,588
+3,417
+28% +$122K ﹤0.01% 2121
2018
Q1
$441K Buy
12,171
+29
+0.2% +$1K ﹤0.01% 2133
2017
Q4
$387K Buy
12,142
+3,800
+46% +$130K ﹤0.01% 2184
2017
Q3
$312K Buy
8,342
+5
+0.1% +$170 ﹤0.01% 2274
2017
Q2
$260K Hold
8,337
﹤0.01% 2291
2017
Q1
$205K Hold
8,337
﹤0.01% 2391
2016
Q4
$211K Buy
+8,337
New +$185K ﹤0.01% 2370

Other funds holding LMAT